375 related articles for article (PubMed ID: 36835558)
1. Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension.
Martin de Miguel I; Cruz-Utrilla A; Oliver E; Escribano-Subias P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835558
[TBL] [Abstract][Full Text] [Related]
2. Immune Cells in Pulmonary Arterial Hypertension.
Ni S; Ji T; Dong J; Chen F; Feng H; Zhao H; Chen D; Ma W
Heart Lung Circ; 2022 Jul; 31(7):934-943. PubMed ID: 35361533
[TBL] [Abstract][Full Text] [Related]
3. An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition.
Hu L; Zhao C; Chen Z; Hu G; Li X; Li Q
Drug Discov Today; 2022 May; 27(5):1457-1463. PubMed ID: 35104622
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
Zeng C; Liu J; Zheng X; Hu X; He Y
Respir Res; 2023 Nov; 24(1):263. PubMed ID: 37915044
[TBL] [Abstract][Full Text] [Related]
5. New progress in diagnosis and treatment of pulmonary arterial hypertension.
Zhang ZQ; Zhu SK; Wang M; Wang XA; Tong XH; Wan JQ; Ding JW
J Cardiothorac Surg; 2022 Aug; 17(1):216. PubMed ID: 36038916
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
He YZ; Wang YX; Ma JS; Li RN; Wang J; Lian TY; Zhou YP; Yang HP; Sun K; Jing ZC
Vascul Pharmacol; 2023 Dec; 153():107216. PubMed ID: 37699495
[TBL] [Abstract][Full Text] [Related]
7.
Peng Y; Dai J; Zhao YY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
[TBL] [Abstract][Full Text] [Related]
8. Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension.
Cober ND; VandenBroek MM; Ormiston ML; Stewart DJ
Hypertension; 2022 Aug; 79(8):1580-1590. PubMed ID: 35582968
[TBL] [Abstract][Full Text] [Related]
9. Non-Muscle MLCK Contributes to Endothelial Cell Hyper-Proliferation through the ERK Pathway as a Mechanism for Vascular Remodeling in Pulmonary Hypertension.
Anis M; Gonzales J; Halstrom R; Baig N; Humpal C; Demeritte R; Epshtein Y; Jacobson JR; Fraidenburg DR
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362426
[TBL] [Abstract][Full Text] [Related]
10. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.
Wang RR; Yuan TY; Wang JM; Chen YC; Zhao JL; Li MT; Fang LH; Du GH
Pharmacol Res; 2022 Jun; 180():106238. PubMed ID: 35504356
[TBL] [Abstract][Full Text] [Related]
11. Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.
Wang J; Liu C; Huang SS; Wang HF; Cheng CY; Ma JS; Li RN; Lian TY; Li XM; Ma YJ; Jing ZC
Eur J Pharmacol; 2024 May; 970():176492. PubMed ID: 38503401
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685
[TBL] [Abstract][Full Text] [Related]
13. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.
Hiraishi K; Kurahara LH; Ishikawa K; Go T; Yokota N; Hu Y; Fujita T; Inoue R; Hirano K
J Smooth Muscle Res; 2022; 58(0):50-62. PubMed ID: 35944979
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.
Zhou J; Li F; Yang Y
Respir Res; 2022 Aug; 23(1):223. PubMed ID: 36042446
[TBL] [Abstract][Full Text] [Related]
15. Stem cell therapy for pulmonary arterial hypertension: An update.
Sun QW; Sun Z
J Heart Lung Transplant; 2022 Jun; 41(6):692-703. PubMed ID: 35341679
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in Pulmonary Arterial Hypertension.
Klouda T; Yuan K
Adv Exp Med Biol; 2021; 1303():351-372. PubMed ID: 33788202
[TBL] [Abstract][Full Text] [Related]
17. CD39 in the development and progression of pulmonary arterial hypertension.
Willcox A; Lee NT; Nandurkar HH; Sashindranath M
Purinergic Signal; 2022 Dec; 18(4):409-419. PubMed ID: 35947229
[TBL] [Abstract][Full Text] [Related]
18. JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension.
Zhang Y; Hernandez M; Gower J; Winicki N; Morataya X; Alvarez S; Yuan JX; Shyy J; Thistlethwaite PA
Sci Transl Med; 2022 May; 14(643):eabl5471. PubMed ID: 35507674
[TBL] [Abstract][Full Text] [Related]
19. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
[TBL] [Abstract][Full Text] [Related]
20. Senescence in pulmonary arterial hypertension: is there a link?
Semen KO; Bast A
Curr Opin Pulm Med; 2022 Jul; 28(4):303-306. PubMed ID: 35749795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
